Condition: Intracerebral Hemorrhage (ICH) · Sponsor: University Hospital, Tours
This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study. The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.
This description comes directly from the study's public registry record.
Marco PASI, Pr · 2.47.47.80.21 · m.pasi@chu-tours.fr
Sophie QUERAUD · 247470156 · s.queraud@chu-tours.fr
Always discuss trial participation with your own doctor first.
| university hospital, Angers | Angers, France | Not Yet Recruiting |
| university hospital, Lille | Lille, France | Not Yet Recruiting |
| University hospital, Toulouse | Toulouse, France | Not Yet Recruiting |
| University hospital | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07444853